MedPath

Low Carb vs Normal Carb in Pregnancy

Not Applicable
Terminated
Conditions
Gestational Diabetes
Interventions
Other: 100 g carbs
Other: MyPlate
Registration Number
NCT03749889
Lead Sponsor
State University of New York at Buffalo
Brief Summary

The overall purpose of this intervention study is to examine whether low-carbohydrate dietary intervention will prevent the development of gestational diabetes mellitus (GDM) in high-risk pregnant women. The results of this study should help further our understanding of how pregnant women can help prevent gestational diabetes mellitus. We hypothesize that a lower carbohydrate diet will prevent the development of GDM.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
11
Inclusion Criteria
  • 18 - 40 years old
  • BMI > 30 and/or history of gestational diabetes mellitus
  • Currently in first trimester of pregnancy with single fetus (e.g. not twins, triplets, etc.)
  • Newborns of current participants
Exclusion Criteria
  • Diabetes (types 1 and 2)
  • History of major chronic disease or blood clotting disorders (e.g., cancer, heart disease, kidney disease, hypertension)
  • Known fetal anomaly
  • History of eating disorders
  • Current use of medications that affect appetite or insulin secretion/sensitivity (e.g. stimulants)
  • Current use of illegal substances, antipsychotic or opioid substitution medications, alcohol, or tobacco

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
100 g carbs100 g carbs100 grams of carbohydrate allowance for the day
MyPlateMyPlateCarbohydrate suggestions based on standard MyPlate. 45-65% kcal intake from carbs.
Primary Outcome Measures
NameTimeMethod
Birth Outcome Questionnaire24 months

Upon delivery of the baby, a birth outcome questionnaire will be collected which includes questions about the delivery and birth of the baby and a question about gestational diabetes. The answer to gestational diabetes or not will be the measure for the outcome.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

SUNY Buffalo

🇺🇸

Buffalo, New York, United States

© Copyright 2025. All Rights Reserved by MedPath